The relationship between excess adiposity and breast cancer appears to be modulated by menopausal status and by breast cancer subtype, which is clinically based on the expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2). This evidence concerns the gene PGR and breast cancer.